Literature DB >> 20542128

The therapeutic approach to non-tuberculous mycobacterial infection of the lung.

Emmet E McGrath1, Paul B Anderson.   

Abstract

Non-tuberculous mycobacteria (NTM) are a group of alcohol fast, aerobic, nonmotile bacteria that are found in the environment. Recent reports indicate that their incidence and prevalence is increasing and guidelines have been developed laying down criteria for diagnosis. The treatment of these mycobacteria may be difficult, in many cases involving complex regimens containing multiple drugs. While traditional anti-tuberculosis medications are frequently used, specific therapeutic regimens depend on the organism isolated, in vitro susceptibility testing, drug tolerance and toxicity and concomitant medical disorders. In this review, we describe the diagnosis and treatment of the more important lung pathogens, describing complexities and controversies surrounding treatment with traditional, adjunctive and the newer and more experimental agents. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542128     DOI: 10.1016/j.pupt.2010.06.002

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  4 in total

1.  Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains.

Authors:  Kimberly E Beatty; Monique Williams; Brian L Carlson; Benjamin M Swarts; Robin M Warren; Paul D van Helden; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

2.  Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China.

Authors:  Hui Pang; Guilian Li; Xiuqin Zhao; Haican Liu; Kanglin Wan; Ping Yu
Journal:  Biomed Res Int       Date:  2015-08-13       Impact factor: 3.411

3.  Identification and characterization of non-tuberculous mycobacteria isolated from tuberculosis suspects in Southern-central China.

Authors:  Xiao-li Yu; Lian Lu; Gao-zhan Chen; Zhi-Guo Liu; Hang Lei; Yan-zheng Song; Shu-lin Zhang
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

4.  Prevalence of nontuberculous mycobacteria and high efficacy of d-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus.

Authors:  Azar Dokht Khosravi; Mehdi Mirsaeidi; Abbas Farahani; Mohammad Reza Tabandeh; Parviz Mohajeri; Saeed Shoja; Seyedeh Roghayeh Hoseini Lar KhosroShahi
Journal:  Infect Drug Resist       Date:  2018-12-07       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.